精神分裂症患者的心血管风险优化计划:试点随机对照临床试验
Journal of psychiatric practice
|November 10, 2023
概括
经过6个月的干预,精神分裂症患者通过改善生活方式和脂质资料显著降低了心血管风险. 这种以患者为中心的方法为管理心血管疾病提供了一个有希望的策略.
科学领域:
- 心脏病学 心脏病学
- 精神病学是一个精神病学.
- 公共卫生 公共卫生
背景情况:
- 心血管疾病是精神分裂症患者过早死亡的主要原因.
- 导致这种风险的可改变因素包括生活方式,药物副作用和并发症.
- 评估这些人群中减轻心血管风险的干预措施至关重要.
研究的目的:
- 为了评估6个月多因素心血管风险干预的有效性.
- 在被诊断为精神分裂症的患者中降低心血管风险 (CVR).
主要方法:
- 进行了一项双臂,并行,随机的临床试验.
- 患有无控制心血管风险因素 (CVRF) 的参与者被分配到干预 (PRISCA) 或对照组.
- 普里斯卡干预包括生活方式促进,CVRF管理,心理药物优化和动机跟进.
主要成果:
- 在6个月后,PRISCA组的心血管风险评分 (REGICOR) 显著降低了-0.96% (P=0.011).
- 这代表干预组的相对风险降低20.9%,而对照组没有显著变化.
- 在PRISCA组中,低密度脂蛋白胆固醇也显著降低了-27.14 mg/dL (P=0.008).
结论:
- 一个以患者为中心的多因素心血管风险干预措施有效地改善了精神分裂症患者的CVR.
- 这种改善的主要机制是提高脂质样本.
- 这种干预表明了在精神分裂症患者心血管风险管理的可行策略.
相关概念视频
Coronary Artery Disease IV: Preventive Measures
23
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
23
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Clinical Trials
6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.8K
Psychoneuroimmunology: Cardiovascular Disease
33
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
33
Hypertension IV: Drug Therapy and Lifestyle Modifications
12
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
12
Atherosclerosis III: Management
11
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11


